ARCHIVES

FDA Approves Ribavirin Phase 102 Trials

This article is from The Cancer Letter archive.

Vol. 13 No. 42 | October 30, 1987

Download PDF Visit The Full Archive

Related Articles

Wyden Compared Taxol To AZT; But Experts Note Lack Of Patent

August 9, 1991

White House Says Upton Appointment Due In Two Weeks

July 29, 1977

Lower Stomach Cancers Increasing In Younger U.S. Whites, Study Finds

May 28, 2010

DOD Names Innovator Award Recipients.

April 26, 2002

Men With PSA Of 7 Or Higher More Likely To Have Biopsy

February 25, 2005

Pretreatment with Azacitidine Achieves 28-Month Remission

August 30, 2013